Nucleoside analogues as antiviral agents.
D000212:Acyclovir; D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001087:Arabinonucleosides / Q000494:pharmacology; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D003561:Cytarabine / Q000031:analogs & derivatives / Q000494:pharmacology; D003857:Deoxyuridine / Q000031:analogs & derivatives / Q000494:pharmacology; D006147:Guanine / Q000031:analogs & derivatives / Q000494:pharmacology; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000031:analogs & derivatives / Q000494:pharmacology; D009705:Nucleosides / Q000494:pharmacology* / Q000627:therapeutic use; D012254:Ribavirin / Q000494:pharmacology; D013936:Thymidine / Q000031:analogs & derivatives / Q000494:pharmacology; D014777:Virus Diseases / Q000188:drug therapy; D014780:Viruses / Q000187:drug effects*
D000998:Antiviral Agents; D001087:Arabinonucleosides; D009705:Nucleosides; D003561:Cytarabine; C022811:edoxudin; C020235:brivudine; C026023:fiacitabine; D012254:Ribavirin; C016391:9-(2,3-dihydroxypropyl)adenine; C021283:5'-amino-5-iodo-2',5'-dideoxyuridine; D006147:Guanine; D001973:Bromodeoxyuridine; D000225:Adenine; D007065:Idoxuridine; C010032:thymine arabinoside; D013936:Thymidine; D003857:Deoxyuridine; D000212:Acyclovir